Seres Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 0
EBIT TTM (mln): -153
index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 22 32 28 35 33 145 7 126 0
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% inf% 47.5% -11.9% 22.1% -3.7% 336.3% -95.1% 1672.2% -100.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% 100.0% 100.0% 100.0% -132.3% -172.7% 98.8% 85.9% 88.0% 0.0%
EBIT (mln) -3 -6 -15 -55 -93 -91 -100 -72 -88 -64 -246 -107 -121
EBIT Δ r/r 0.0% 99.5% 149.2% 263.7% 69.2% -1.6% 9.7% -28.3% 22.6% -26.8% 282.2% -56.5% 13.1%
EBIT (%) 0.0% 0.0% 0.0% 0.0% -426.5% -284.7% -354.8% -208.3% -265.3% -44.5% -3458.1% -84.9% nan
Koszty finansowe (mln) 0 0 0 1 1 2 1 1 3 3 6 13 0
EBITDA (mln) -3 -6 -13 -55 -86 -84 -100 -68 -86 -63 -244 -92 -121
EBITDA(%) 0.0% 0.0% 0.0% 0.0% -397.0% -262.1% -354.8% -197.9% -259.5% -43.2% -3425.0% -73.0% nan
Podatek (mln) 0 0 2 -1 2 -2 1 -6 -3 -4 4 0 0
Zysk Netto (mln) -3 -6 -17 -55 -92 -89 -99 -64 -86 -61 -254 -114 0
Zysk netto Δ r/r 0.0% 95.2% 173.8% 227.8% 67.2% -2.4% 10.7% -35.1% 34.6% -28.9% 312.7% -55.2% -100.1%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% -420.7% -278.4% -350.0% -186.2% -260.3% -42.4% -3560.9% -90.0% nan
EPS -0.15 -0.2 -0.56 -2.33 -2.3 -2.21 -2.43 -1.13 -1.08 -0.67 -2.35 -0.89 0.0009
EPS (rozwodnione) -0.15 -0.2 -0.56 -2.33 -2.3 -2.21 -2.43 -1.13 -1.08 -0.67 -2.35 -0.89 0.0009
Ilośc akcji (mln) 21 30 30 24 40 40 41 57 80 92 108 128 155
Ważona ilośc akcji (mln) 21 30 30 24 40 40 41 57 80 92 108 128 155
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD